ArticleJournal of clinical pharmacology2019

Single-Dose Pharmacokinetics and Safety of Solriamfetol in Participants With Normal or Impaired Renal Function and With End-Stage Renal Disease Requiring Hemodialysis.

Katie Zomorodi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.